Johnson & Johnson (JNJ) Stock Price, Quote & News

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 732 524 0400

Website: www.jnj.com

Address:

One Johnson & Johnson Plaza, New Brunswick, United States

sister Aug. 5 at 9:59 PM

$PFE Moderna ($MRNA) overdue for Snapback to 35.59 w/that new Cancer Vaccine and Earnings Beat on Revenue Estimates for COVID Vaccine $JNJ $VRTX $LLY

0 · Reply

SqueezeGod Aug. 5 at 6:16 PM

$JNJ time for liftoff

0 · Reply

xMonti Aug. 5 at 4:04 PM

$STAA bad news for long term investors . one time $5.6 billion dollar valuation company sold for $1.5 billion . $JNJ should offer $500M more . Surprised why Broadwood, Vanguard & Blackrock agree ? EVO ICL likely to cut contact lens market by huge % in next decade or so

0 · Reply

DoDaMan Aug. 5 at 3:41 PM

$JNJ LFG $200

0 · Reply

Night_Owl_Biotech Aug. 5 at 2:26 PM

$SNDX is up this morning but, at $12.27/share, has a market cap of $1.051B per Yahoo Finance. SNDX's market cap is ~0.14X cumulative 10-year revenue estimates while peers are generally acquired for 0.33 to 0.42X their 10-year revenue estimates. SNDX revenue estimates do not consider Niktimvo US sales (recorded by $INCY) which means any Niktimvo US valuation does not manifest in SNDX's multiples. This is not investment advice because there may be a very good reason SNDX trades at such a large discount to its hypothetical M&A valuation using peer multiples. $VRNA published the financial projection provided $JNJ this morning. VRNA's 10-year revenue projections were roughly 20% higher than analyst consensus at the time the acquisition was announced. Hence VRNA's 10-year revenue multiple using their own estimates was 0.36X. Again, this is not investment advice as we've never been able to predict what will happen to the price of any stock. $XBI

3 · Reply

NicholasABrown Aug. 5 at 1:58 PM

For the first time ever Palantir $PLTR now has a larger market cap than Johnson & Johnson $JNJ

0 · Reply

wha1e Aug. 5 at 1:20 PM

$SPY $AZN $MRNA $PFE $JNJ lmfao, up to potentially “250%” tariff rates

1 · Reply

Messerschmittbf109 Aug. 5 at 1:17 PM

$JNJ $LLY $MRK $NVO $PFIZER.NSE Perfect time…

0 · Reply

theoptionsplug Aug. 5 at 12:56 PM

Trump says pharma tariffs could eventually reach up to 250% - CNBC $JNJ $PFE $LLY $NVO $MRK

2 · Reply

EddieCash Aug. 5 at 12:53 PM

Sold $JNJ and added $ALGN

0 · Reply

Why Johnson & Johnson Stock Still Has Room To Run

Aug 2, 2025, 8:01 AM EDT - 3 days ago

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8.5% (August 2025)

ADP AMH APH ARCC ASR AVGO BTI

Aug 1, 2025, 12:01 PM EDT - 4 days ago

Pharmaceutical makers were largely unshaken by new demands from President Trump to lower drug prices, with experts saying the measures would either have modes impact or face legal challenges

ABBV AMGN AZN BMY GILD GSK LLY

Aug 1, 2025, 9:11 AM EDT - 4 days ago

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields

BAX MDT

Aug 1, 2025, 8:31 AM EDT - 4 days ago

Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

ABBV ABT ALNY AMGN ARGX AZN BAX

Aug 1, 2025, 6:54 AM EDT - 4 days ago

President Trump demands drugmakers slash prices within 60 days

ABBV ABT ALNY AMGN ARGX AZN BAX

Jul 31, 2025, 3:35 PM EDT - 5 days ago

Pharma Companies Should Immediately Cut Down Drug Prices, Trump Says

ABBV AMGN AZN BMY GILD GSK LLY

Jul 31, 2025, 3:00 PM EDT - 5 days ago

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days.

ABBV AMGN AZN BMY GILD GSK LLY

Jul 31, 2025, 2:28 PM EDT - 5 days ago

Trump pressures 17 pharma CEOs to cut US drug prices

ABBV AMGN AZN BMY GILD GSK LLY

Jul 31, 2025, 2:19 PM EDT - 5 days ago

Trump posts letters to 17 pharmaceutical companies about drug prices

ABBV GILD LLY PFE AMGN AZN BMY

Jul 31, 2025, 1:48 PM EDT - 5 days ago

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days

ABBV AMGN AZN BMY GILD GSK LLY

Jul 30, 2025, 4:32 PM EDT - 6 days ago

Johnson & Johnson to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Jul 29, 2025, 7:11 PM EDT - 7 days ago

Boston Jury Hits Johnson & Johnson with Record $42M Verdict in Asbestos Baby Powder Case

Jul 29, 2025, 8:03 AM EDT - 7 days ago

Johnson & Johnson Launches VIRTUGUIDE™ AI-Powered Patient-Matched Lapidus System in U.S. to Reduce Complexity in Bunion Surgery for Millions

Jul 29, 2025, 8:00 AM EDT - 7 days ago

Johnson & Johnson files with U.S. FDA to include new evidence in TREMFYA® (guselkumab) label as the only IL-23 inhibitor to demonstrate significant inhibition of joint structural damage in active psoriatic arthritis

Jul 27, 2025, 12:14 PM EDT - 9 days ago

22 Dividend Kings At Discounted Valuations

ABM ADM AMZN AWR BDX BKH CWT

Jul 27, 2025, 11:45 AM EDT - 9 days ago

20 Kiplinger July Dividend Favorites: No Cigars

APD BDX DUK EPD GS HD KVUE

Jul 25, 2025, 1:49 PM EDT - 11 days ago

3 Pharma Stocks That Aren't Sweating the Coming 200% Drug Tariffs

LLY NVS

Jul 25, 2025, 11:48 AM EDT - 11 days ago

US FDA says J&J's Ethicon issues correction related to surgical stapler

Jul 24, 2025, 4:30 PM EDT - 12 days ago

Johnson & Johnson to Participate in the 2025 Wells Fargo Healthcare Conference

Jul 23, 2025, 6:00 PM EDT - 13 days ago

How To Build A $100,000 Dividend Portfolio: Targeting A Yield Of 15%+ In 20 Years

AAPL BLK GOOG GOOGL HDV PEP RQI

Jul 22, 2025, 3:11 PM EDT - 14 days ago

Johnson & Johnson Stock Could Be Waking Up

Jul 22, 2025, 9:31 AM EDT - 14 days ago

Best Dividend Kings: July 2025

ABBV ABM ABT ADM ADP AWR BDX

Jul 21, 2025, 10:50 AM EDT - 15 days ago

Insider report: These stocks had the biggest sales by executives in the past week

AVAV COST DFH HEI MS PAYX

Jul 21, 2025, 8:00 AM EDT - 15 days ago

Johnson & Johnson seeks first icotrokinra U.S. FDA approval aiming to revolutionize treatment paradigm for adults and adolescents with plaque psoriasis

Jul 17, 2025, 8:05 PM EDT - 19 days ago

Jim Cramer explains why Johnson & Johnson rallied after 'surprise' earnings results

Jul 17, 2025, 7:47 PM EDT - 19 days ago

JNJ gave us a manual on how to spot a stock that can soar after earnings, says Jim Cramer

Jul 17, 2025, 4:37 PM EDT - 19 days ago

Stock Of The Day: Breakout In Johnson & Johnson

Jul 17, 2025, 12:40 PM EDT - 19 days ago

Johnson & Johnson: The Worst Is Baked In

Jul 17, 2025, 9:32 AM EDT - 19 days ago

Johnson & Johnson Analysts Raise Their Forecasts After Upbeat Earnings

Jul 17, 2025, 8:00 AM EDT - 19 days ago

Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer

Jul 17, 2025, 7:59 AM EDT - 19 days ago

Dow Futures flat amid latest Trump vs Powell fiasco: 5 things to know before Wall Street opens today

Jul 16, 2025, 5:40 PM EDT - 20 days ago

S&P 500 Gains and Losses Today: Johnson & Johnson Stock Jumps; Universal Health Services Shares Slide

UHS

Jul 16, 2025, 4:00 PM EDT - 20 days ago

JNJ Technicals & Takeaways After Earnings, Healthcare Reaching Key Levels

Jul 16, 2025, 3:36 PM EDT - 20 days ago

Johnson & Johnson (JNJ) Q2 2025 Earnings Call Transcript

Jul 16, 2025, 2:10 PM EDT - 20 days ago

Johnson & Johnson Stock Jumps on Strong Earnings, Higher Outlook

Jul 16, 2025, 1:52 PM EDT - 20 days ago

Final Trades: Johnson & Johnson, ICE and the IBIT

IBIT ICE

Jul 16, 2025, 12:40 PM EDT - 20 days ago

Top Stock Movers Now: J&J, ASML, Tesla, and More

Jul 16, 2025, 11:30 AM EDT - 20 days ago

J&J CFO: We're pleased with the engagement with the Trump administration

Jul 16, 2025, 10:51 AM EDT - 20 days ago

Cramer's Mad Dash: Johnson & Johnson

Jul 16, 2025, 7:27 AM EDT - 20 days ago

J&J CFO Joseph Wok on Q2 results: 2025 is shaping up to be better than what we'd thought

Jul 16, 2025, 7:20 AM EDT - 20 days ago

Johnson & Johnson Tops Q2 Estimates, Lifts Outlook for Sales and Profit

Jul 16, 2025, 6:28 AM EDT - 20 days ago

Johnson & Johnson's stock rallies after earnings beat and outlook raised, amid strength in heart and cancer treatments

Jul 16, 2025, 6:27 AM EDT - 20 days ago

Johnson & Johnson beats profit estimates on strong Darzalex, medtech sales

Jul 16, 2025, 6:25 AM EDT - 20 days ago

Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2025

Jul 16, 2025, 6:20 AM EDT - 20 days ago

Johnson & Johnson Reports Q2 2025 Results; Raises 2025 Outlook

Jul 14, 2025, 10:05 AM EDT - 22 days ago

Johnson & Johnson: Buy JNJ Stock Ahead of Its Upcoming Earnings?

Jul 13, 2025, 2:00 PM EDT - 23 days ago

Wells Fargo, Citi, Netflix, J&J, and More Stocks to Watch This Week

NFLX C WFC

Jul 11, 2025, 12:01 PM EDT - 25 days ago

Mar Vista U.S. Quality Q2 2025 Top Contributors And Detractors

AAPL AVGO MSFT ORCL

Jul 11, 2025, 3:41 AM EDT - 25 days ago

Johnson & Johnson Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

sister Aug. 5 at 9:59 PM

$PFE Moderna ($MRNA) overdue for Snapback to 35.59 w/that new Cancer Vaccine and Earnings Beat on Revenue Estimates for COVID Vaccine $JNJ $VRTX $LLY

0 · Reply

SqueezeGod Aug. 5 at 6:16 PM

$JNJ time for liftoff

0 · Reply

xMonti Aug. 5 at 4:04 PM

0 · Reply

DoDaMan Aug. 5 at 3:41 PM

$JNJ LFG $200

0 · Reply

Night_Owl_Biotech Aug. 5 at 2:26 PM

3 · Reply

NicholasABrown Aug. 5 at 1:58 PM

For the first time ever Palantir $PLTR now has a larger market cap than Johnson & Johnson $JNJ

0 · Reply

wha1e Aug. 5 at 1:20 PM

$SPY $AZN $MRNA $PFE $JNJ lmfao, up to potentially “250%” tariff rates

1 · Reply

Messerschmittbf109 Aug. 5 at 1:17 PM

$JNJ $LLY $MRK $NVO $PFIZER.NSE Perfect time…

0 · Reply

theoptionsplug Aug. 5 at 12:56 PM

Trump says pharma tariffs could eventually reach up to 250% - CNBC $JNJ $PFE $LLY $NVO $MRK

2 · Reply

EddieCash Aug. 5 at 12:53 PM

Sold $JNJ and added $ALGN

0 · Reply

francophile Aug. 5 at 12:45 PM

Top dividend stocks candidates: - Johnson & Johnson ($JNJ): Yield ~3.6%, price up 2.22% today, trading near 52-week high at 171.04, comfortably above 50-day (157.81) and 200-day (155.58) moving averages, momentum building. Strong fundamentals and steady dividend growth. - Mc Donald’s ($MCD): Yield ~3.5%, price up 0.44% today, trading near 52-week high at 304.23, above 50-day (300.16) and 200-day (301.28) moving averages, showing stable momentum. - Procter & Gamble ($PG): Yield ~3.3%, price flat today but holding above 50-day (159.81) and 200-day (165.58) moving averages, recent price action stabilizing after minor pullback. - Nike ($NKE): Yield ~3.2%, price up 0.27% today, above 50-day (68.35) and 200-day (70.59) moving averages, momentum improving

0 · Reply

NotYoCupATea Aug. 5 at 5:51 AM

$JNJ $SPY Umm… GUYS!… HEEEELLLPPP!!!

0 · Reply

sister Aug. 4 at 11:39 PM

$PFE what about Moderna with that new Cancer Vaccine and possibly even more upside than Pfizer? $MRNA $JNJ

1 · Reply

Wenwenwenwenwenwen Aug. 4 at 11:03 PM

$JNJ $200 next imo…

0 · Reply

COLDBREW Aug. 4 at 8:00 PM

$JNJ why is this trash up

0 · Reply

Aporia Aug. 4 at 7:05 PM

$GS $JNJ early (for me) but stayed

0 · Reply

theoptionsplug Aug. 4 at 6:54 PM

$JNJ broke its long term wedge and is PUSHING $175.60 is the first price target then $181 RSI isn't high so lots of room to the upside

0 · Reply

sister Aug. 4 at 6:51 PM

$PFE could Moderna ($MRNA) after unjustified Selldown be biggest beneficiary of Pfizer Earnings tomorrow? $LLY $JNJ

1 · Reply

MessAndGetHorns Aug. 4 at 6:40 PM

$ESTA She's running ahead of earnings on August 7th. Absolutely killing it in the breast implant market. Expecting huge US market share taking. $70 incoming! $ABBV $JNJ $SPY $QQQ

0 · Reply

scientificway Aug. 4 at 6:28 PM

$JNJ check MDXG out, huge rev, eps, guidance up. Support at 6.9, chance to buy below 7.3. How much next year?,

0 · Reply

ZacksResearch Aug. 4 at 5:17 PM

$JNJ lifts 2025 outlook — but can it deliver on higher growth targets? Strong Q2 results, MedTech gains, and new drug launches are driving the momentum, with top-line growth expected to accelerate in 2H. Full breakdown here 👉 https://www.zacks.com/stock/news/2661592/jj-expects-better-top-line-growth-in-2h-can-it-achieve-the-goal?cid=sm-stocktwits-2-2661592-teaser-5819&ADID=SYND_STOCKTWITS_TWEET_2_2661592_TEASER_5819

0 · Reply

ZacksResearch Aug. 4 at 3:40 PM

$JNJ just raised its 2025 sales guidance by $2B — why this bullish momentum? 🚀 📈 Innovative Medicine & MedTech units outperformed, with key drugs in both segments beating estimates. 💊 New product launches and currency tailwinds are driving growth. 🛡️ Lowered tariff impact, along with other factors, is boosting EPS guidance. Find out what could drive JNJ’s next breakout 👉 https://www.zacks.com/stock/news/2661592/jj-expects-better-top-line-growth-in-2h-can-it-achieve-the-goal?cid=sm-stocktwits-2-2661592-body-5723&ADID=SYND_STOCKTWITS_TWEET_2_2661592_BODY_5723

0 · Reply

Market Cap	402.99B
Revenue (ttm)	88.82B
Net Income (ttm)	14.07B
EPS (ttm)	N/A
PE Ratio	16.47
Forward PE	15.17
Profit Margin	15.84%
Debt to Equity Ratio	0.50

Volume	7,934,400
Avg Vol	8,405,624
Day's Range	N/A - N/A
Shares Out	2.41B
Stochastic %K	98%
Beta	0.41
Analysts	Sell
Price Target	$175.18